In the Media Tag: prostate cancer SARDS


New Molecules May Offer Treatment Option for Some Aggressive Prostate Cancers

In the Media Icon

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla. “If successful in the clinic,… Read More